{"disease":{"id":"gastric-cardia-body-cancer","name":"gastric cardia body cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00341276","title":"Esophageal Cancer Genetics Studies","phase":"","overall_status":"COMPLETED","enrollment_count":7705,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06028737","title":"Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Ukrainian Society of Clinical Oncology","has_results":false},{"nct_id":"NCT06702683","title":"The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":112,"lead_sponsor_name":"Lin Liu","has_results":false},{"nct_id":"NCT06904300","title":"Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07018063","title":"Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":35,"lead_sponsor_name":"zhoujing","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}